ISRCTN66445141已完成不适用
Omega-3-polyunsaturated fatty acids and atherosclerosis in systemic lupus erythematosus: cellular mechanisms and functional consequences
Queen's University of Belfast (UK)0 个研究点目标入组 60 人开始时间: 2005年7月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Patients (adult, either sex) fulfilling American College of Rheumatology (ACR) classification criteria for SLE.
排除标准
- •1. Diabetes mellitus (fasting blood glucose more than 7.8 mmol/l)
- •2. Hypertension of systolic more than 160 mmHg or diastolic more than 90 mmHg (as determined by the mean of three readings taken on the first visit)
- •3. Carcinoma (other than superficial skin carcinoma)
- •4. Significant pulmonary, hepatic or renal disease
- •5. Typical angina or myocardial infarction
- •6. Active infectious diseases
- •7. Use of antihypertensive, oral hypoglycaemic or lipid lowering agent (in the last three months)
- •8. Cyclophosphamide therapy (due to potential to interfere with acetylcholinesterase)
- •9. Glucocorticoids equivalent to greater than 10 mg prednisolone
- •10. All pregnant or lactating women will be excluded.
研究者
相似试验
进行中（未招募）
1 期
Omega-3-Polyunsaturated Fatty Acids and Atherosclerosis in Systemic Lupus Erythematosus: Cellular Mechanisms and Functional Consequences - Fish oils in LupusSystemic Lupus ErythematosusEUCTR2004-004404-21-GBGreenPark Healthcare Trust60
已完成
不适用
The effect of omega-3 in the prevention of cardiac complications after PCIChronic ischaemic heart disease.Atherosclerotic heart diseaseIRCT2016072329035N1Ardabil University of Medical Sciences100
已完成
不适用
Effect of omega-3 fatty acid on endothelial dysfunction induced by postprandial hypelipidemiaHealthy subjectsJPRN-UMIN000012556Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences10
已完成
2 期
The effect of omega 3 polyunsaturated fatty acid supplementation on inflammatory markers and insulin resistanse factors in patients with Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseCondition 1: type 2 diabetes. Condition 2: Nonalcoholic fatty liver disease (NAFLD).Non-insulin-dependent diabetes mellitusFatty (change of) liver, not elsewhere classified (NAFLD)IRCT2017103030489N2Yazd Shahid Sadoughi University of Medical Sciences48
已完成
2 期
Effect of omega-3 fatty acid supplementation in patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.Condition 1: type 2 diabetes. Condition 2: Nonalcoholic fatty liver disease (NAFLD).Non-insulin-dependent diabetes mellitusFatty (change of) liver, not elsewhere classified (NAFLD)IRCT2016102530489N1Yazd Shahid Sadoughi University of Medical Sciences60